# Kerry J. Savage

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kerry-j-savage/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,773 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 86 |
| i10-index | 254 |
| Last Known Institution | BC Cancer Agency |
| OpenAlex ID | https://openalex.org/A5017873196 |
| ORCID iD | https://orcid.org/0000-0002-5835-9863 |
| Works | 648 |

## Researcher papers

- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers](https://scholariq.org/papers/mhc-class-ii-transactivator-ciita-is-a-recurrent-gene-fusion-partner-in-lymphoid/)
- [Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial](https://scholariq.org/papers/adjuvant-vemurafenib-in-resected-brafv600-mutation-positive-melanoma-brim8-a/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)

## Researcher university

- [BC Cancer Agency](https://scholariq.org/institutions/bc-cancer-agency/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.